Because readers are likely to encounter and assess individual publications, NHS EED abstracts reflect the original publication as it is written, as a stand-alone paper. Where NHS EED abstractors are able to identify positively that a publication is significantly linked to or informed by other publications, these will be referenced in the text of the abstract and their bibliographic details recorded here for information.
Bergemann R, Suissa S, Morris A, et al. A simulation model for diabetes mellitus type I and II: model description and internal validation process with UKPDS, DCCT, and WESDR data. Diabetalogia 2001;44 Suppl 1:A114.
Bagust A, Beale S. Modelling EuroQoL health-related utility values for diabetic complications from CODE-2 data. Health Econ 2005;14:217-30.
Fritsche A, Schweitzer MA, Haring HU, 4001 Study Group. Glimepiride combined with morning insulin glargine, bedtime neutral protamine Hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes: a randomized controlled trial. Ann Intern Med 2003;138:952-9.
Schmitt-Koopmann I, Schwenkglenks M, Spinas GA, et al. Direct medical costs of type 2 diabetes and its complications in Switzerland. Eur J Public Health 2004;14:3-9.
Yki-Jarvinen H, Kauppinen-Makelin R, Tiikkainen M, et al. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study. Diabetologia. 2006;49:442-5.